Motor impairment
dopamine
DA
neuronal activity
proenkephalin
PENK
gene expression
caudate-putamen
CPu
6-OHDA-lesioned
treated (
CB1
KO
WT mice
lesion
induced
6-OHDA
severe
motor deterioration
CB1
KO mice
loss
DA
increased
PENK gene
CPu
Oxidative/nitrosative
neuroinflammatory
parameters
CPu
cingulate cortex
Cg
CB1
MDA
levels
iNOS
protein expression
CPu
Cg
WT mice
Treatment
L-DOPA+benserazide
weeks
severe
dyskinesias
CB1
KO
WT mice
cannabinoid
CB1 receptors
increased
severity
motor impairment
DA lesion
reduced
L-DOPA-induced dyskinesias
results
activation
CB1 receptors
neuroprotection
dopaminergic lesion
development
L-DOPA-induced dyskinesias
